All lobbying filings
The KPM Group DC LLC
The KPM Group DC LLC filed a Q4 termination report for Astria Therapeutics, Inc. on January 20, 2026, reporting $40,000 in lobbying income.
Lobbying for Astria Therapeutics, Inc. · Develop therapies for patients with HAE, rare, and niche allergic and immunologic diseases
Filing · LD-2 quarterly report
Q4 termination
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Representation ended
Dec 31, 2025
The registrant reported terminating its work for this client.
Government bodies contacted
2
Lobbying activity
1
S.864, Help Ensure Lower Patient (HELP) Copays Act H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act (118th Congress) H.R.1532/S.822, Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1262/S.932, Give Kids a Chance Act H.R.1990, American Innovation and R&D Competitiveness Act H.R.1414, Camerons Law